Client Services:800-959-2846|Billing:949-374-5019
Client Services:800-959-2846|Billing:949-374-5019
Signed in as:
filler@godaddy.com
While squamous cell carcinoma has steadily decreased since the introduction on the Pap smear, adenocarcinoma remains an area of great concern. The ability to detect adenocarcinoma is an essential part of comprehensive cervical cancer screening.
Virtually all cervical cancers are caused by HPV infections. However, the vast majority of infections regress. Several genetic abnormalities have been identified and correlated with the transformation of cervical cells to carcinoma. The identification of these genetic abnormalities can be used to predict which patients are likely to progress to cervical carcinoma.
FISH Assays:
TERC (3q26): Research has indicated that in increased copy number of the TERC gene is a strong predictor of progression from CIN1/CIN2 to CIN3 and invasive carcinoma in cervical lesions.1,2
MYC (8q24 ): Studies have demonstrated that a copy number increase in either 8q24 (MYC) and/or 3q26 (TERC) has the ability to identify which patients with a cervical cytology diagnosis of LSIL are most likely to have or progress to CIN2+ on clinical follow up.3
CTNND2 (5p15): Studies have revealed copy number gains in 5p in 43% of cervical carcinomas. These studies have demonstrated gains of the entire 5p chromosomal arm which contains numerous potential oncogenes including CTNND2 at 5p15.4
References
Review our requisition for a complete list of the Women's Health services that we provide.
We have partnered with Hologic's Aptima® platform to provide an extensive menu of FDA approved assays.
HPV 16, 18/45 Genotype: The Aptima® HPV assay targets E6/E7 mRNA and identifies high-risk HPV infections that are present and active.
CT/NG: Chlamydia and Gonorrhea are often asymptomatic infections. A recent study estimated that 45% of tubal factor infertility cases were caused by chlamydia infections.
Mycoplasma Genitalium: M.gen can be difficult to detect because the bacterial organism load is low compared to other STIs commonly tested for. This means that a highly sensitive rRNA test is needed for accurate diagnosis.
Trichomonas Vaginalis: The Aptima TV assay has been shown to be 97% sensitive for the detection of Trichomonas vaginalis. As part of the CV/TV assay, the specificity range is 95-99% by collection device.
Bacterial Vaginosis: The Aptima® BV assay provides a clear diagnosis for BV with a high sensitivity of 95-97% and specificity of 86-90%. The assay targets three indicators of the vaginal microbiome: Lactobacillus, G. vaginalis, and A. vaginae.
Candida Vaginitis: The assay qualitatively reports Candida species group (C. albicans, C. tropicalis, C. parapsilosis, and C. dubliniensis) and Candida glabrata. The assay has a sensitivity of 85-93% and specificity of 91-99%.
Review our requisition for a complete list of the Women's Health services that we provide.
Copyright © 2025 Emeritus Medical Technology - All Rights Reserved.